These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


344 related items for PubMed ID: 7590880

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Regulation of CD44-hyaluronan interactions in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid B cells by PMA and interleukin-4.
    Kryworuchko M, Gee K, Diaz-Mitoma F, Kumar A.
    Cell Immunol; 1999 May 25; 194(1):54-66. PubMed ID: 10357881
    [Abstract] [Full Text] [Related]

  • 3. Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines.
    Stickeler E, Runnebaum IB, Möbus VJ, Kieback DG, Kreienberg R.
    Anticancer Res; 1997 May 25; 17(3C):1871-6. PubMed ID: 9216637
    [Abstract] [Full Text] [Related]

  • 4. Interferon-gamma inhibits CD44-hyaluronan interactions in normal human B lymphocytes.
    Kryworuchko M, Diaz-Mitoma F, Kumar A.
    Exp Cell Res; 1999 Jul 10; 250(1):241-52. PubMed ID: 10388538
    [Abstract] [Full Text] [Related]

  • 5. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma.
    Ermak G, Jennings T, Robinson L, Ross JS, Figge J.
    Cancer Res; 1996 Mar 01; 56(5):1037-42. PubMed ID: 8640758
    [Abstract] [Full Text] [Related]

  • 6. IL-4 induces LFA-1 and LFA-3 expression on Burkitt's lymphoma cell lines. Requirement of additional activation by phorbol myristate acetate for induction of homotypic cell adhesions.
    Rousset F, Billaud M, Blanchard D, Figdor C, Lenoir GM, Spits H, De Vries JE.
    J Immunol; 1989 Sep 01; 143(5):1490-8. PubMed ID: 2547869
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression of CD44 and variant isoforms in cultured human retinal pigment epithelial cells.
    Liu NP, Roberts WL, Hale LP, Levesque MC, Patel DD, Lu CL, Jaffe GJ.
    Invest Ophthalmol Vis Sci; 1997 Sep 01; 38(10):2027-37. PubMed ID: 9331266
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells.
    Galluzzo E, Albi N, Fiorucci S, Merigiola C, Ruggeri L, Tosti A, Grossi CE, Velardi A.
    Eur J Immunol; 1995 Oct 01; 25(10):2932-9. PubMed ID: 7589094
    [Abstract] [Full Text] [Related]

  • 13. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.
    Fox SB, Fawcett J, Jackson DG, Collins I, Gatter KC, Harris AL, Gearing A, Simmons DL.
    Cancer Res; 1994 Aug 15; 54(16):4539-46. PubMed ID: 7519124
    [Abstract] [Full Text] [Related]

  • 14. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA, Gotley DC, Walsh MD, Fawcett J, Antalis TM.
    Cancer Res; 1998 Aug 15; 58(16):3719-26. PubMed ID: 9721884
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of CD44 variants 6 and 7 in human endometrial cancer.
    Katsura M, Furumoto H, Nishimura M, Kamada M, Aono T.
    Gynecol Oncol; 1998 Nov 15; 71(2):185-9. PubMed ID: 9826458
    [Abstract] [Full Text] [Related]

  • 16. Hyaluronate binding assay study of transfected CD44 V4-V7 isoforms into the human gastric carcinoma cell line SC-M1.
    Harn HJ, Shen KL, Liu CA, Ho LI, Yang LS, Yueh KC.
    J Pathol; 1998 Mar 15; 184(3):291-6. PubMed ID: 9614382
    [Abstract] [Full Text] [Related]

  • 17. Transient expression of CD44 variant isoforms in the ontogeny of the rat: ectoderm-, endoderm- and mesoderm-derived cells express different exon combinations.
    Weber B, Rösel M, Arch R, Möller P, Zöller M.
    Differentiation; 1996 Mar 15; 60(1):17-29. PubMed ID: 8935925
    [Abstract] [Full Text] [Related]

  • 18. CD4 mRNA expression in CD19-positive B cells and its suppression by the Epstein-Barr virus.
    Zhang RD, Henderson EE.
    Virology; 1994 Feb 15; 198(2):709-13. PubMed ID: 7507284
    [Abstract] [Full Text] [Related]

  • 19. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF, Zhu D, Bourguignon LY.
    J Cell Physiol; 1995 Sep 15; 164(3):605-12. PubMed ID: 7544357
    [Abstract] [Full Text] [Related]

  • 20. Cell phenotype-dependent splicing reflecting differential promoter usage for EBNA transcripts in EBV-carrying cells.
    Hu LF, Chen F, Altiok E, Winberg G, Klein G, Ernberg I.
    Gan To Kagaku Ryoho; 2000 May 15; 27 Suppl 2():248-60. PubMed ID: 10895161
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.